- Canadian scientists first to test novel diagnostic tool for TB in bison
To help protect Canada’s cattle and bison and maintain the country’s bovine tuberculosis-free status, scientists are conducting trials in bison of several diagnostic tools, including the Actiphage® blood test developed by PBD Biotech.
- VIDO-InterVac approved to work on Wuhan coronavirus
Researchers have received permission from the Public Health Agency of Canada to start working on a vaccine for the coronavirus recently discovered in China, and they hope to have first candidates for testing in an animal model in six to eight weeks.
- Increasing Canada’s Preparedness for African swine fever with the University of Saskatchewan’s VIDO-InterVac
VIDO-InterVac is the first non-government facility in Canada to work with the ASF virus
- Mild Zika infection in fetuses may cause brain abnormalities
Using a relevant animal model (pigs) researchers have shown that mild Zika virus infection in fetuses can cause abnormal brain development in apparently healthy young animals.
- USask’s VIDO-InterVac and South Korean’s International Vaccine Institute to undertake scientific exchanges
USask’s VIDO-InterVac and South Korea’s International Vaccine Institute (IVI) have signed a memorandum of understanding (MOU) to share expertise and best practices in vaccine development to benefit human and animal health globally.
- Novel vaccination approach enhances worker safety
A novel approach to vaccinating sows, gilts and their piglets offers a new method of preventing disease that is safer for barn workers.
- Canada needs small-scale vaccine manufacturing to support research, and help save human and animal lives
It is critical to accelerate the development of Canadian vaccine technologies—and in the timeframes necessary—to support new vaccine commercialization and help enable emergency preparedness.
- TB in bison studied at LFCE and VIDO-InterVac
A Parks Canada scientist is conducting research at the University of Saskatchewan (USask) on bovine tuberculosis in bison to improve diagnosis of the disease and to develop better vaccines.
- Dr. Andy Potter among Saskatchewan Order of Merit recipients
Dr. Potter is one of six people to receive the province's highest honour this year.
- Reverse vaccinology approach for novel bovine tuberculosis vaccines: The Canadian ReVAMP project
Researchers are taking a reverse vaccinology approach to develop new vaccines against bTB. Read more in the OiE Panorama, Controlling bovine tuberculosis: a One Health challenge